Skip To Main Content
Barrios CH on Muck Rack

Barrios CH

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barrios

Contact Barrios, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2- early breast cancer - PubMed

|
By Slamon DJ, Fasching PA, Barrios CH, Im SA
| ncbi.nlm.nih.gov
doi: 10.1177/17588359231178125. Affiliations Affiliations 1 David Geffen School of Medicine at UCLA, 10945 Le Conte Ave. Suite 3360, Los Angeles, CA 90095, USA. 2 University Hospital Erlangen Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. 3 University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. 4 British Columbia Cancer Agency, Vancouver, BC, Canada. 5 St. Vincent's Hospital, Dublin, Ireland.
Open in Who Shared Issue with article?

Results of a survey study on health professionals' perceptions of tumor boards in Brazil

|
By Menezes TU, Serra MM, Barrios CH, Oliveira LJ
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (607) Issue with article?

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01) - PubMed

|
By Barrios CH, Ruiz-Borrego M, Guerrero-Zotano Á, García-Sáenz JA
| nlm.nih.gov
Clinical Trial doi: 10.1200/JCO.19.00904. Affiliations Affiliations 1 Hospital Clínico Universitario de Valencia and Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. 2 Centro de Investigación Biomédica en Red de Oncología ISCIII, Madrid, Spain. 3 GEICAM, Spanish Breast Cancer Group, Madrid, Spain. 4 Centro de Pesquisa Clínica Hospital São Lucas da PUCRS, Porto Alegre, Brazil. 5 LACOG, Latin American Cooperative Oncology Group, Porto Alegre, Brazil.
Open in Who Shared Issue with article?
See all 3 articles